Carmen Bozic Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Carmen Bozic is EVP and CMO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 23,259 shares of VRTX, which is worth approximately $11.7 Million. The most recent transaction as insider was on Aug 07, 2024, when has been sold 2,280 shares (Common Stock) at a price of $476.75 per share, resulting in proceeds of $1,086,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K

0% 3M change

33.45% 12M change

Total Value Held $11.7 Million

Carmen Bozic Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 07 2024	SELL Open market or private sale	$1,086,990 $476.75 p/Share	2,280 Reduced 8.93%	23,259 Common Stock
Jul 24 2024	SELL Open market or private sale	$1,113,688 $488.46 p/Share	2,280 Reduced 8.2%	25,539 Common Stock
Jul 10 2024	SELL Open market or private sale	$1,111,135 $487.34 p/Share	2,280 Reduced 7.58%	27,819 Common Stock
Jun 26 2024	SELL Open market or private sale	$1,075,521 $471.72 p/Share	2,280 Reduced 7.04%	30,099 Common Stock
Jun 12 2024	SELL Open market or private sale	$1,089,840 $478.0 p/Share	2,280 Reduced 6.58%	32,379 Common Stock
May 29 2024	SELL Open market or private sale	$1,015,876 $445.56 p/Share	2,280 Reduced 6.17%	34,659 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$1,428,793 $431.79 p/Share	3,309 Reduced 8.22%	36,939 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$1,182,670 $420.58 p/Share	2,812 Reduced 6.53%	40,248 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$1,590,037 $424.01 p/Share	3,750 Reduced 8.01%	43,060 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$887,754 $422.74 p/Share	2,100 Reduced 4.29%	46,810 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	5,928 Added 10.81%	48,910 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	13,680 Added 24.14%	42,982 Common Stock
Nov 14 2023	SELL Open market or private sale	$2,151,633 $380.82 p/Share	5,650 Reduced 16.17%	29,302 Common Stock
Oct 31 2023	SELL Open market or private sale	$2,011,303 $355.92 p/Share	5,651 Reduced 13.92%	34,952 Common Stock
Oct 17 2023	SELL Open market or private sale	$2,109,235 $373.25 p/Share	5,651 Reduced 12.22%	40,603 Common Stock
Oct 03 2023	SELL Open market or private sale	$1,951,177 $345.28 p/Share	5,651 Reduced 10.89%	46,254 Common Stock
Sep 19 2023	SELL Open market or private sale	$1,983,501 $351.0 p/Share	5,651 Reduced 9.82%	51,905 Common Stock
Sep 05 2023	SELL Open market or private sale	$1,992,881 $352.66 p/Share	5,651 Reduced 8.94%	57,556 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$956,408 $289.12 p/Share	3,308 Reduced 4.97%	63,207 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,098,187 $292.85 p/Share	3,750 Reduced 5.34%	66,515 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,488,913 $298.26 p/Share	4,992 Reduced 6.63%	70,265 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$796,751 $294.33 p/Share	2,707 Reduced 3.47%	75,257 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	28,452 Added 26.74%	77,964 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$84,356 $271.24 p/Share	311 Reduced 0.62%	49,512 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$283,002 $227.86 p/Share	1,242 Reduced 2.43%	49,823 Common Stock

Carmen Bozic

EVP and CMO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account